Commentary · 29 Dec 2025
Conference abstractPublished 31 Aug 2017
Analyzing cancer genomics using watson for genomics with structural variants
IBM Research, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Statement of the Problem: As sequencing cost declines, more cancer patients have their tumor samples sequenced to seek for optimum treatments. However, analyzing genomic data requires considerable expertise and efforts. Besides, reports should be generated in clinically relevant time frame, without errors, with objectivity, and in comprehensive manner. It is difficult to meet those criteria in ever increasing flood of new publications, clinical trial information on investigational drugs, and more highresolution data. As an example of high resolution data, structural variant data is available. However, so far, fusion proteins such as BCR-ABL, EML4-ALK receives attentions; other types of structural variants such as simple disrupts, exon skippings, intron retentions, and internal tandem duplications are underestimated. Methodology & Theoretical Orientation: Watson for Genomics (WfG) takes variants, copy number alterations, and gene expressions as inputs to generate a report in automated manner. WfG performs molecular profile to identify driver mutations and drug response biomarkers followed by drug analysis including pathway analysis. Structural variants module is being developed to accommodate structural variant data. Findings: WfG generates reports with high recall rates in drug recommendation compared with human experts using whole genome samples from collaborators such as New York Genome Center and British Columbia Cancer Agency. Structural variants such as EGFR vIII, MET exon skipping event, and tumor suppressor gene disruptions are successfully captured along with de novo events. WfG provides cancer communities with up to date knowledge to benefit their patients.
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Perspective · 26 Feb 2025
Accurate Fine-mapping of Structural Variants in Elusive Rare Diseases Using Optical Genome Mapping Technology
Research article · 6 Oct 2016
Analyzing the association between XRCC1 c.1804C A genetic variant and lung cancer susceptibility in the Chinese population
Article · 23 Sep 2024
Analyzing Genome-Phenome Associations across the Eukaryotic Phylogeny
Commentary · 18 Sep 2024
Genomic Insights: Analyzing the Hidden Genetic World of Fungi
More from this journal
The newest in Transcriptomics: Open Access.
Commentary · 30 Dec 2025
Transcriptomic Biomarkers for Early Diagnosis and Prognosis of Diseases
Commentary · 30 Dec 2025
Metatranscriptomics for Understanding Microbial Community Functionality
Commentary · 30 Dec 2025
Single-Nucleus Transcriptomics in Neurological Disorder Research
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalTranscriptomics: Open Access
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Takahiko Koyama”

